“…Neurotransmitters, such as dopamine (DA, hsa04728), serotonin (5-HT, hsa04726), and acetylcholine (ACh, has04725) work on muscarinic acetylcholine receptor M2 (CHRM2) [46] and MAOA for DA metabolism in glial cells, as well as on CHRNA7 [47] and CHRM1 [48] for calcium (Ca 2+ ) storage by Ca 2+ -induced Ca 2+ release (CICR) [49], and on HTR2A-SLC6A4-IP3-TRPC1 [50,51] pathway for Ca 2+ transport, respectively. On the postsynaptic cell membrane, DA, is the prototypical slow neurotransmitter of the mammalian brain, which interacts with D1-like receptors DRD1 and DRD5 [52,53], both positively coupled to adenylyl cyclase (AC) and cAMP production, which are activated and regulated downstream of PTGS1 and NOS1 expression. While the activation of D2-like receptors DRD2, DRD3, and DRD4 have exactly the reverse effect on regulating the production of AC and cAMP in dopaminergic synapse pathway The left panel of Figure 6 shows that SLC18A1, 2, and 3 may have a role in synaptic vesicle cycling, acetylcholinesterase (ACHE) [42], and amine oxidase [flavin-containing] A (MAOA) [43,44] signaling, which have been shown to be involved in tryptophan metabolism, clycerophospholipid metabolism, and also related to cocaine and amphetamine addiction, as well as alcoholism, and Parkinson's disease in the presynaptic nerve terminal.…”